A critical breakthrough in cancer research is occurring with the use of nanobodies to re-engage dysfunctional p53. This vital tumor inhibitor protein is frequently disabled in many forms of tumors, causing uncontrolled https://myfirstbookmark.com/story21966213/vhh-fragments-revive-tumor-suppressor-p53-the-promising-hope-for-tumor-treatment